Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacovigilance

UK regulator appeals to patients with animation about reporting drug side effects

Mick Foy, group manager for the MHRA’s vigilance and risk management of medicines division

Source: The Medicines and Healthcare products Regulatory Agency

Mick Foy says the campaign “will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference”

A short animation about the value of reporting drug side effects is being used as part of a social media campaign by the UK’s drug safety watchdog.

The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medicines and medical devices in the UK, hopes the animation, available on YouTube, will encourage patients to report side effects directly or to inform health professionals about the side effects they are experiencing so they can be officially recorded.

Mick Foy, group manager for the MHRA’s vigilance and risk management of medicines division, says: “Our campaign will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference.”

He says any suspected side effects can be reported easily and quickly through the MHRA’s Yellow Card scheme, either online or via a mobile app.

The MHRA campaign, which began on 7 November 2016 and will run until 11 November 2016, is part of the Europe-wide Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) joint action project. The project is being supported by 22 EU member states.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201926

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Remington Education: Drug Information and Literature Evaluation

    Remington Education: Drug Information and Literature Evaluation

    Remington Education: Drug Information & Literature Evaluation teaches students how to effectively and efficiently locate and analyze up-to-date drug information and literature.

    £27.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now
  • Pharmacy and the US Health Care System

    Pharmacy and the US Health Care System

    A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.

    £49.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Mick Foy, group manager for the MHRA’s vigilance and risk management of medicines division

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.